MPWT
ACRS icon

MassMutual Private Wealth & Trust’s Aclaris Therapeutics ACRS Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.07K Buy
+391
New +$1.74K ﹤0.01% 2000
2023
Q2 		– Sell
-71
Closed -$574 – 1900
2023
Q1 		$574 Buy
71
+1
+1% +$13 ﹤0.01% 1656
2022
Q4 		$1K Hold
70
– – ﹤0.01% 1383
2022
Q3 		$1K Buy
70
+15
+27% +$236 ﹤0.01% 1334
2022
Q2 		$1K Hold
55
– – ﹤0.01% 1240
2022
Q1 		$1K Buy
+55
New +$750 ﹤0.01% 1242

Other funds holding ACRS

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
CAL
Capital Advisors Ltd Shaker Heights, Ohio $991M AUM 19.82% 1-Year Est. Return

MassMutual Private Wealth & Trust's ACRS Position: Q2 2026 in Review

MassMutual Private Wealth & Trust opened a new position in Aclaris Therapeutics (ACRS) in Q2 2026: 391 shares worth $2.07K. The stake represents ﹤0.01% of the portfolio and ranks #2000 among its holdings. This is a return to the name: MassMutual Private Wealth & Trust previously reported a position in ACRS as recently as Q1 2023.

MassMutual Private Wealth & Trust first reported a position in ACRS in Q1 2022 and has held it in 6 quarters since. 7 funds tracked by Wall St. Rank hold ACRS as of Q2 2026.

  • MassMutual Private Wealth & Trust held 391 shares of Aclaris Therapeutics worth $2.07K as of Q2 2026.
  • Aclaris Therapeutics was a new MassMutual Private Wealth & Trust position in Q2 2026.
  • Aclaris Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #2000 holding.
  • MassMutual Private Wealth & Trust first reported a position in Aclaris Therapeutics in Q1 2022 and has held it in 6 quarters since.
  • 7 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.